In PrEP: Long-acting antivirals for HIV prevention

被引：1
|
作者：
Sharma, Amit [1 ]
机构：
[1] Ohio State Univ, Dept Microbial Infect & Immun, Dept Vet Biosci, Columbus, OH 43210 USA
来源：
CELL HOST & MICROBE | 2022年 / 30卷 / 02期
基金：
美国国家卫生研究院;
关键词：
PROPHYLAXIS; EFFICACY; MEN;
D O I：
10.1016/j.chom.2022.01.012
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Two recent publications (Vidal et al., 2021; Xue et al., 2022) report highly potent inhibitors as candidates for HIV pre-exposure prophylaxis (PrEP). They provide strong evidence that administration of long-acting capsid or fusion inhibitors as PrEP offers robust protection against simian-human immunodeficiency virus in the rhesus macaque model of HIV infection.
引用
收藏
页码：148 / 150
页数：3
相关论文
共 50 条
  • [21] Equitable access to long-acting PrEP on the way?
    不详
    LANCET HIV, 2022, 9 (07): : E449 - E449
  • [22] Willingness to use long-acting injectable PrEP among key populations at a large HIV prevention clinic in Kampala, Uganda
    Lukubuya, D.
    Baguma, M.
    Kaguta, A.
    Nambatya, W.
    Kyambadde, P.
    Katana, E.
    Muwonge, T.
    Odongpiny, E.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 31 - 31
  • [23] Long-Acting Injectable Antiretroviral Agents for HIV Treatment and Prevention
    Kim, Yeon-Sook
    INFECTION AND CHEMOTHERAPY, 2021, 53 (04): : 686 - 695
  • [24] Long-acting drugs and formulations for the treatment and prevention of HIV infection
    Flexner, Charles
    Owen, Andrew
    Siccardi, Marco
    Swindells, Susan
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (01)
  • [25] The promise and pitfalls of long-acting injectable agents for HIV prevention
    Landovitz, Raphael J.
    Kofron, Ryan
    McCauley, Marybeth
    CURRENT OPINION IN HIV AND AIDS, 2016, 11 (01) : 122 - 128
  • [26] Long-acting injectable multipurpose prevention technology for prevention of HIV and unplanned pregnancy
    Young, Isabella C.
    Pallerla, Aryani
    Cottrell, Mackenzie L.
    Maturavongsadit, Panita
    Prasher, Alka
    Shrivastava, Roopali
    Cruz, Gabriela De la
    Montgomery, Stephanie A.
    Schauer, Amanda
    Sykes, Craig
    Kashuba, Angela D. M.
    Benhabbour, S. Rahima
    JOURNAL OF CONTROLLED RELEASE, 2023, 363 : 606 - 620
  • [27] Preparing for long-acting PrEP delivery: provider preferences for the provision of long-acting PrEP differ between MSM and heterosexual individuals in Europe
    Zimmermann, Hanne
    Wang, Haoyi
    Kolstee, Johann
    Lozano, Alejandro Adriaque
    Schroeder, Melanie
    Appiah, Ama
    Milinkovic, Ana
    Sakar, Supriya
    Jonas, Kai
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 31 - 32
  • [28] Long-acting PrEP: new opportunities with some drawbacks
    Xiridou, Maria
    Hoornenborg, Elske
    LANCET HIV, 2023, 10 (04): : E213 - E215
  • [29] Long-acting cabotegravir PrEP: a time for cautious optimism
    Griffin, David W. J.
    Hoy, Jennifer F.
    McMahon, James H.
    LANCET HIV, 2023, 10 (12): : E756 - E757
  • [30] Long-acting antiretrovirals: a new era for the management and prevention of HIV infection
    Thoueille, Paul
    Choong, Eva
    Cavassini, Matthias
    Buclin, Thierry
    Decosterd, Laurent A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (02) : 290 - 302
12345